AMETEK, Inc. (AME) Down 4.6% — Cut and Run?

  • AME fell 4.61% to $238.73 from $250.28 the previous trading day
  • Weiss Ratings assigns B+ (Buy)
  • Market cap is $57.38B with a dividend yield of 0.53%

AMETEK, Inc. (AME) is under pressure on Thursday, last trading at $238.73 on the NYSE. That is an $11.55 decline from the prior close of $250.28. The pullback leaves the stock about 8.6% below its 52-week high of $261.16, set on August 13, 2026, and erases a large share of the ground the stock gained after its strong summer earnings report. Even after today's drop, AME is still trading within reach of that peak, but the speed of the move is notable for a name that has generally traded with less turbulence than the broader industrial complex.

Volume so far stands at roughly 231,452 shares with the session still in progress, compared with a 90-day average of about 1.29 million. That puts turnover at under a fifth of a typical full day's activity at the time of this quote.


Why AMETEK, Inc. Price is Moving Lower

The most plausible driver is a broad risk-off move tied to renewed Middle East supply fears, with AMETEK falling harder than the overall market. Before the open, U.S. equity futures were down 0.9% for the S&P 500 and 1.6% for the Nasdaq 100. Brent crude climbed 2.6% to $111.60 a barrel on reports of increased Houthi attacks on Saudi Arabia and possible renewed U.S.-Israeli strikes on Iran. Oil above $110 raises input and energy costs across manufacturing, and it threatens the industrial demand outlook that premium-valued equipment makers depend on. AME's slide has outpaced the index futures. A 10:31 a.m. ET shares were down as much as 5.75% to $235.89 before they recovered part of the loss.

The selling has concentrated in cyclical industrials. Caterpillar Inc. (CAT) is down 5.19% and GE Vernova Inc. (GEV) has dropped 9.76%, both moves at least as severe as AMETEK's. Defense names are moving the other way. Lockheed Martin Corporation (LMT) is up 6.59% as geopolitical escalation pushes investors toward military contractors. That split shows the market is rotating out of economically sensitive industrial growth and into perceived conflict beneficiaries. AME has also been carrying a forward P/E of 36.59, a rich multiple that leaves the stock more exposed when investors cut risk across the group.

The selloff arrives despite a solid operating backdrop. AMETEK's most recent quarter, reported on August 4, delivered adjusted EPS of $2.09 against a $1.99 estimate. Revenue of $2.04 billion topped the $1.95 billion consensus and rose 15% year over year. Management raised its 2026 adjusted EPS outlook to a range of $8.20 to $8.30, up from $7.94 to $8.14. The next test comes quickly: AMETEK has scheduled its Q3 results for November 3 before the market opens. Some investors appear to be reducing exposure ahead of that report while macro uncertainty is high.


What is the AMETEK, Inc. Rating - Should I Sell?

Weiss Ratings assigns AME a B+ rating. Current recommendation is Buy. Today's decline does not change the underlying profile, which remains among the stronger in its peer group. Still, a near-5% drop on macro fears shows that even a high-quality name can lose ground quickly when its valuation is elevated.

The core of the rating rests on fundamentals that are hard to fault. AMETEK is rated Excellent on the Growth Index, Efficiency Index, and Solvency Index. Revenue growth of 14.98% supports the Growth Index rating, and that is double-digit expansion for a diversified instruments and electromechanical maker, not a single-product story riding one cycle. A 20.04% profit margin backs the Excellent rating on the Efficiency Index. That margin is strong for a capital goods company and reflects pricing power in niche, highly engineered markets. ROE of 14.56% is respectable rather than spectacular, but it holds up across a business that has expanded heavily through acquisitions. The Excellent Solvency Index suggests the balance sheet can keep funding that deal strategy without strain. The Total Return Index is also rated Excellent, because the stock reached a 52-week high just two months ago and remains within about 9% of it even after today's drop.

Where the picture becomes more nuanced is in the Volatility Index and the Dividend Index. The Volatility Index is rated Good rather than Excellent, and today's session illustrates why. A geopolitical oil shock pulled AME down more sharply than the broad index futures, a reminder that the stock's premium multiple can amplify market-wide selling. The Dividend Index is rated Fair. A 0.53% yield makes AMETEK a capital-compounding story rather than an income holding, and investors looking for meaningful cash returns will find little support here.

Within the Industrials sector, AMETEK ranks ahead of Caterpillar Inc. (CAT, B), General Electric Company (GE, B), and GE Vernova Inc. (GEV, B), and above Lockheed Martin Corporation (LMT, B-). In Weiss's framework, that places AMETEK among the more favorable risk/reward profiles in the group, though the sector as a whole is facing the same macro headwinds today.


About AMETEK, Inc.

AMETEK, Inc. (AME) is an Industrials company that designs and manufactures electronic instruments and electromechanical devices for a broad range of industrial and commercial customers. Headquartered in Berwyn, Pennsylvania, the company runs two primary segments. The Electronic Instruments Group produces advanced analytical, test and measurement, and monitoring instruments for the process, aerospace, power, and industrial markets. These include spectrometers, materials analysis equipment, power quality monitors, and precision measurement systems. The Electromechanical Group supplies precision motion control products, specialty metals, electrical interconnects, thermal management systems, and engineered components for aerospace and industrial applications.

The company's strategy centers on leadership in specialized, high-value niche markets where its products are critical to customer operations and represent a small share of total system cost. That positioning supports pricing power and helps explain AMETEK's margin profile. Acquisitions are a central pillar of the model. The company has built a long track record of buying differentiated technology businesses and integrating them through its operational excellence program, which focuses on cost discipline, lean manufacturing, and global sourcing.

AMETEK's competitive advantages come from its diversification across end markets and geographies, its deep engineering expertise, and the installed base of instruments that generates recurring service and replacement demand. Its exposure to aerospace, energy, medical, research, and automation customers spreads risk across multiple economic cycles. The business is still not immune to broader industrial slowdowns or to cost pressures tied to energy and materials.


Investor Outlook

AMETEK, Inc. (AME) carries a Weiss Rating of B+ (Buy), backed by Excellent ratings across growth, efficiency, solvency, and total return. Today's macro-driven selloff, however, shows how exposed the stock's premium valuation is to geopolitical and oil-price shocks. The November 3 Q3 report is the key near-term checkpoint, and investors should watch whether management holds or lifts its $8.20 to $8.30 adjusted EPS outlook while crude trades above $110. See full rankings of all B+ rated Industrials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
AAPL NASDAQ $356.27
B
NVDA NASDAQ $162.85
B
MSFT NASDAQ $523.88
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $128.09
B
Top Financial Stocks
See All »
A
A
JPM NYSE $346.19
B
V NYSE $425.76
Top Energy Stocks
See All »
B
CVX NYSE $219.89
B
COP NYSE $142.28
Top Health Care Stocks
See All »
B
LLY NYSE $1,443.50
B
JNJ NYSE $285.75
B
ABBV NYSE $295.03
Top Real Estate Stocks
See All »
B
PLD NYSE $128.67
B
EQIX NASDAQ $1,053.79